(Press-News.org) SAN DIEGO (March 15, 2015) --The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S. registry presented at the American College of Cardiology's 64th Annual Scientific Session.
Healthy valves function as one-way gates that keep blood moving forward through the heart. Severely damaged mitral valves don't close properly, allowing blood to leak backward. If the valve isn't repaired or replaced, the condition can cause serious health issues or death. An estimated 600,000 people in the United States have a severely leaking mitral valve, called primary or degenerative mitral regurgitation, and some are medically unfit for repair surgery.
In 2013, the FDA approved the transcatheter MitraClip system for valve repair in patients with degenerative mitral regurgitation who face prohibitive risk from open-heart surgery. It remains the only commercially approved alternative to surgical repair of mitral regurgitation, the most common heart valve problem, and is available in Europe and at about 100 U.S. centers. FDA approval came with a requirement for all patients treated with this system to be enrolled in the American College of Cardiology/Society of Thoracic Surgeons Transcatheter Valve Therapy Registry; coverage by the Centers for Medicare and Medicaid Services carries the same stipulation.
This is the first study of outcomes with transcatheter mitral valve repair outside of a clinical trial since the system was approved. Analyses are based on data from the ACC/STS registry, gathered from 61 hospitals for 564 patients who underwent the procedure between November 2013 and August 2014.
"Our results show that the transcatheter MitraClip system is a safe and effective valve repair treatment for patients with symptomatic mitral regurgitation whose surgical risk is prohibitive," said Paul Sorajja, M.D., director of the Center for Valve and Structural Heart Disease, Minneapolis Heart Institute and the study's principal investigator. "Similar to other transcatheter therapies, TMVR with MitraClip has an operator learning curve, which directs interest to outcomes now that the procedure is being performed outside the context of a clinical trial."
The study's main outcome was success of the procedure, defined as a reduction in mitral regurgitation to a level of moderate or less without later heart surgery or in-hospital death. By this measure, valve repair was successful for 518 patients, or 91.8 percent, and also reduced mitral regurgitation to mild or less in 63.7 percent. Researchers found that institutional experience with the procedure and case volume had a bearing on procedural success but not on major adverse outcomes, complications or device-related events.
In-hospital mortality was 2.3 percent, and four of the 13 patient deaths were from heart-related causes. Other outcomes of interest were clinically significant events within 30 days of the procedure. The rate for stroke or transient ischemic attack, a brief stroke-like event often called a mini-stroke, was 1.2 percent, and there were no heart attacks. Procedural complications arose in 7.8 percent of patients, and device-related events appeared in 2.7 percent. At 30 days of follow-up, 5.8 percent, or 26 patients, had died, 15 of them from heart events; the stroke rate was 1.6 percent; and 8 percent had re-entered the hospital for heart failure.
"Overall, procedure success rates were high, procedural complication and device-related event rates were low, and hospital stays were quite short at an average of three days," Sorajja said. "In addition, 82 percent of the patients were discharged directly to home from the hospital with another 10 percent discharged directly to extended care. These results are remarkable, especially when one considers that these patients are elderly with significant morbidities."
When patients are eligible for either TMVR or surgery, surgery reduces mitral regurgitation more effectively. Sorajja emphasized that TMVR is approved for patients at prohibitive risk from open-heart surgery--patients whose risk of serious injury or death from surgery outweighs the potential benefits. The study's findings are not applicable to lower-risk patients, although smaller studies have shown similar survival rates for TMVR and surgery in lower-risk patients with different degrees of decrease in mitral regurgitation.
Limitations of this study include dependence on site-reporting of outcomes and its focus only on the in-hospital and early outcomes.
"More long-term follow-up is needed to address the clinical significance of residual mitral regurgitation in these and other TMVR-treated patients, but these data give considerable insight into the commercial use of this procedure in the United States," Sorajja said. "The Transcatheter Valve Registry will allow us to continue to collect and analyze data to improve our understanding of the impact of this treatment option."
INFORMATION:
Abbott Laboratories manufactures the device but did not sponsor this research. Sorajja has commercial ties to the company.
The ACC's Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention. Follow @ACCMediaCenter and #ACC15 for the latest news from the meeting.
The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.
Police are ill-equipped to investigate non-criminal deaths and face a challenge to avoid re-traumatising bereaved families as well as emotionally protecting themselves, according to QUT research.
Investigating death: the emotional and cultural challenges for police found it was usually junior officers sent to sudden death investigations and tasked with not only gathering evidence, but also comforting family members and explaining the coronial process.
The research has been published in the journal of Policing and Society.
"The vast majority of deaths are neither ...
NEW YORK, NY - Researchers have built a new computational tool that identifies 800 different ways people are at increased risk for post-traumatic stress disorder (PTSD), permitting for the first time a personalized prediction guide.
Results from the study out of NYU Langone Medical Center are published online (date) in the journal BMC Psychiatry.
"Our study shows that high-risk individuals who have experienced a traumatic event can be identified less than two weeks after they are first seen in the emergency department," says Arieh Y. Shalev, MD, the Barbara Wilson ...
NEW YORK, March 15, 2015 - Most physicians are aware of the importance of lifestyle factors in preventing cardiovascular disease (CVD) -- and believe diet is as important as statin therapy and exercise, according to a new survey from NYU Langone Medical Center.
Researchers found that a majority of doctors would welcome additional training in diet and nutrition so that they can effectively inform patients on the subject. The study will be presented at the American College of Cardiology's 64th Annual Scientific Session as a poster presentation.
The 28-question online survey, ...
NEW YORK, March 4, 2015 - Air pollution has been linked to a dangerous narrowing of neck arteries that occurs prior to strokes, according to researchers at NYU Langone Medical Center.
The scientists analyzed medical test records for more than 300,000 people living in New York, New Jersey or Connecticut. They found that people living in zip codes with the highest average levels of fine-particulate-matter pollution were significantly more likely to show signs of narrowing (stenosis) in their internal carotid arteries, compared to those living in zip codes with the lowest ...
March 16, 2015, New York, NY - Exploring the fundamental mechanism by which a cell-surface receptor transmits its signal, an international team of Ludwig researchers and their colleagues has established proof of concept for an entirely new approach to drug design. They report that a class of synthetic molecules known as diabodies can, from outside the cell, latch onto a target receptor and manipulate it in such a manner as to induce distinct and varying effects within cells and tissues. Led by Christopher Garcia of Ludwig Stanford, the researchers show in lab experiments ...
Carnivorous plants have strange-shaped leaves, and they can grow on nutrient-poor environments by trapping and eating small animals. Charles Darwin, often called "the father of evolution", was also interested in carnivorous plants, and he wrote a book titled "Insectivorous Plants" published in 1875. Since then a lot of researches have been done, but how such strange-shaped leaves were altered during evolution remained unknown.
A research team in Japan has revealed how carnivorous pitcher leaves are formed in Sarracenia purpurea, a carnivorous plant native to North America. ...
Establishing protected areas in forests is one way to keep deforestation at bay and safeguard biodiversity. However, a study led by researchers from the National University of Singapore (NUS) has revealed that such a measure is ineffective in the case of biodiversity-focused protected areas in Indonesia.
The research, led by Assistant Professor Roman Carrasco of the Department of Biological Sciences at the NUS Faculty of Science and Assistant Professor Alex Cook of NUS' Saw Swee Hock School of Public Health, found that the monitoring and prevention of road construction ...
According to a meta-analysis published in BMC Family Practice, high dose zinc acetate lozenges may help shorten diverse symptoms associated with the common cold.
The common cold is an infection caused by over a hundred viruses, and it is a major cause of days off school or work and visits to a doctor.
A previous meta-analysis of three randomized trials found that high dose zinc acetate lozenges shorten the duration of colds by 42%. Since all of the three studies reported the duration of diverse respiratory symptoms and of systemic symptoms such as muscle ache and headache, ...
To increase the biomass of fish, contemporary ecological theory predicts that either the amount of food or the quality of the food has to increase. In a recent experiment, researchers at Umeå University doubled the fish biomass under identical food supply and food quality by only controlling how much of total food supply that was channelled to juvenile and adult fish, respectively. The results have major implications for the exploitation (harvest) of fish populations and the coexistence of predatory fish and their prey.
To increase the biomass of a population, contemporary ...
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
The study was jointly conducted by Doctor Marie-Agnès Doucey (Experimental oncology, Centre Ludwig de l'UNIL pour la recherche sur le cancer), Professor Ioannis Xenarios (UNIL, SIB, Vital-IT) ...
